Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis.

IF 5 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Journal of Clinical Endocrinology & Metabolism Pub Date : 2025-01-21 DOI:10.1210/clinem/dgae223
Xiaowen Zhang, Ka-Shing Cheung, Lung-Yi Mak, Kathryn C B Tan, Annie W C Kung, Ian Chi-Kei Wong, Ching-Lung Cheung
{"title":"Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis.","authors":"Xiaowen Zhang, Ka-Shing Cheung, Lung-Yi Mak, Kathryn C B Tan, Annie W C Kung, Ian Chi-Kei Wong, Ching-Lung Cheung","doi":"10.1210/clinem/dgae223","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Bone metabolism interplays with liver metabolism, also known as the liver-bone axis. Osteoporosis is a common complication of cirrhosis, but whether bone mineral density (BMD) can predict cirrhosis development is unknown.</p><p><strong>Objective: </strong>This study aims to investigate the relationship between BMD and the risk of incident cirrhosis in the Hong Kong Osteoporosis Study (HKOS).</p><p><strong>Methods: </strong>BMD was measured at the lumbar spine, femoral neck, total hip, and trochanter of 7752 participants by dual-energy x-ray absorptiometry (DXA), and the incidence of cirrhosis and mortality were followed by linking to the territory-wide electronic health records database. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CI.</p><p><strong>Results: </strong>With a median follow-up of 18.43 years, 42 incident cirrhosis were identified. Higher BMD T-scores at the femoral neck, total hip, and trochanter were significantly associated with a reduced risk of cirrhosis (femoral neck: HR 0.56; 95% CI, 0.39-0.82; total hip: HR 0.60; 95% CI, 0.44-0.82; trochanter: HR 0.63; 95% CI, 0.46-0.88). Similar associations were observed in participants without risk factors of cirrhosis at the baseline and further adjusting for the baseline level of alkaline phosphatase, albumin, and alanine transaminase. Consistent relationships in multiple sensitivity analyses suggest the robustness of the results.</p><p><strong>Conclusion: </strong>Low BMD could be a novel risk factor and early predictor for cirrhosis, with consistent associations observed in multiple sensitivity analyses.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e276-e282"},"PeriodicalIF":5.0000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae223","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Bone metabolism interplays with liver metabolism, also known as the liver-bone axis. Osteoporosis is a common complication of cirrhosis, but whether bone mineral density (BMD) can predict cirrhosis development is unknown.

Objective: This study aims to investigate the relationship between BMD and the risk of incident cirrhosis in the Hong Kong Osteoporosis Study (HKOS).

Methods: BMD was measured at the lumbar spine, femoral neck, total hip, and trochanter of 7752 participants by dual-energy x-ray absorptiometry (DXA), and the incidence of cirrhosis and mortality were followed by linking to the territory-wide electronic health records database. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CI.

Results: With a median follow-up of 18.43 years, 42 incident cirrhosis were identified. Higher BMD T-scores at the femoral neck, total hip, and trochanter were significantly associated with a reduced risk of cirrhosis (femoral neck: HR 0.56; 95% CI, 0.39-0.82; total hip: HR 0.60; 95% CI, 0.44-0.82; trochanter: HR 0.63; 95% CI, 0.46-0.88). Similar associations were observed in participants without risk factors of cirrhosis at the baseline and further adjusting for the baseline level of alkaline phosphatase, albumin, and alanine transaminase. Consistent relationships in multiple sensitivity analyses suggest the robustness of the results.

Conclusion: Low BMD could be a novel risk factor and early predictor for cirrhosis, with consistent associations observed in multiple sensitivity analyses.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低骨矿密度是肝硬化的风险因素:一项前瞻性队列研究
背景:骨代谢与肝代谢相互影响,又称肝骨轴。骨质疏松症是肝硬化的常见并发症,但骨矿物质密度(BMD)能否预测肝硬化的发展尚不清楚:本研究旨在调查香港骨质疏松症研究(HKOS)中骨密度与肝硬化发病风险之间的关系:方法:采用双能 X 射线吸收仪(DXA)测量了 7,752 名参与者腰椎、股骨颈、全髋和转子的 BMD,并与全港电子健康记录数据库连接,跟踪肝硬化发病率和死亡率。研究采用 Cox 比例危险模型估算危险比(HR)和 95% CI:中位随访时间为 18.43 年,共发现 42 例肝硬化。股骨颈、全髋和转子处较高的 BMD T 值与肝硬化风险的降低显著相关(股骨颈:HR 0.56,95% CI 0.39 至 0.82;全髋:HR 0.60,95% CI 0.60):股骨颈:HR 0.56,95% CI 0.39 至 0.82;全髋:HR 0.60,95% CI 0.44 至 0.82;转子:HR 0.63,95% CI 0.46 至 0.88)。在基线没有肝硬化风险因素的参与者中,以及进一步调整碱性磷酸酶、白蛋白和丙氨酸转氨酶的基线水平后,也观察到了类似的关联。多个敏感性分析中的关系一致,表明结果的稳健性:低 BMD 可能是肝硬化的一个新的风险因素和早期预测因子,在多个敏感性分析中观察到了一致的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
期刊最新文献
Potential mechanism associated with post-heart transplantation diabetes mellitus in Chinese patients. TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer. "Houston We Have a Problem….": Raising the Quality and Authenticity of Manuscripts Submitted to JCEM. "Response to Letter to the Editor from Lin et al.: "Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial". Bone Health and Linear Growth in Children with Familial Hypoparathyroidism Treated with Human Parathyroid Hormone 1-34.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1